Research
Pilot study tests cell therapy for difficult-to-heal diabetic foot ulcers
The Brief
- An experimental cell therapy was well tolerated in 10 people with chronic diabetic foot ulcers.
- The study was a first-in-human pilot led by researchers at Wake Forest Institute for Regenerative Medicine (WFIRM).
- The source describes the study as testing a therapy for difficult-to-heal diabetic foot ulcers; it does not report efficacy results in the summary provided.
Why it matters
This early first-in-human study provides initial tolerability data for a cell therapy aimed at hard-to-heal diabetic foot ulcers, a step toward larger trials that would be needed to show whether it helps healing.
Who’s affected
- clinicians who treat diabetic foot ulcers
- patients with chronic diabetic foot ulcers
- regenerative medicine researchers
- #cell therapy
- #diabetic foot ulcer
- #regenerative medicine
- #clinical trial
- #wound healing
An experimental cell therapy was well tolerated in 10 people with chronic diabetic foot ulcers, according to a first-in-human study led by researchers at Wake Forest Institute for Regenerative Medicine (WFIRM).